A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Modulation of S6 Fibrillation by Unfolding Rates and Gatekeeper Residues

Pedersen, J. S., Christensen, G., & Otzen, D. E. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.020 · Cited by 118

Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., McGarvey, N. H., Rutherford, N. J., Ceballos‐Diaz, C., Robertson, J., Golde, T. E., & Giasson, B. I. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1268-0 · Cited by 119

A simple algorithm locates β‐strands in the amyloid fibril core of α‐synuclein, Aβ, and tau using the amino acid sequence alone

Zibaee, S., Makin, O. S., Goedert, M., & Serpell, L. C. (2007) · Protein Science · doi:10.1110/ps.062624507 · Cited by 116

A Topological Model of the Interaction between α-Synuclein and Sodium Dodecyl Sulfate Micelles

Bisaglia, M., Tessari, I., Pinato, L., Bellanda, M., Giraudo, S., Fasano, M., Bergantino, E., Bubacco, L., & Mammi, S. (2004) · Biochemistry · doi:10.1021/bi048448q · Cited by 114

Structural and mechanistic basis behind the inhibitory interaction of PcTS on α-synuclein amyloid fibril formation

Lamberto, G. R., Binolfi, A., Orcellet, M. L., Bertoncini, C. W., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902603106 · Cited by 113

Multiple phosphorylation of α‐synuclein by protein tyrosine kinase Syk prevents eosin‐induced aggregation

Negro, A., Brunati, A. M., Donella‐Deana, A., Massimino, M. L., & Pinna, L. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0517fje · Cited by 112

Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications

Alza, N. P., González, P. A. I., Conde, M. A., Uranga, R. M., & Salvador, G. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00175 · Cited by 116

α-Synuclein pathology as a target in neurodegenerative diseases

Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 121

In Vitro Formation of Amyloid from α-Synuclein Is Dominated by Reactions at Hydrophobic Interfaces

Pronchik, J., He, X., Giurleo, J. T., & Talaga, D. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102896h · Cited by 111

Assays for α-synuclein aggregation

Giehm, L., Lorenzen, N., & Otzen, D. E. (2010) · Methods · doi:10.1016/j.ymeth.2010.12.008 · Cited by 115

Amyloid Fibril Formation of α-Synuclein Is Accelerated by Preformed Amyloid Seeds of Other Proteins

Yagi, H., Kusaka, E., Hongo, K., Mizobata, T., & Kawata, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508623200 · Cited by 113

The Interplay between Alpha-Synuclein Clearance and Spreading

da Fonseca, T. L., Villar‐Piqué, A., & Outeiro, T. F. (2015) · Biomolecules · doi:10.3390/biom5020435 · Cited by 115

Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants

Tosatto, L., Horrocks, M. H., Dear, A. J., Knowles, T. P. J., Serra, M. D., Cremades, N., Dobson, C. M., & Klenerman, D. (2015) · Scientific Reports · doi:10.1038/srep16696 · Cited by 112

The Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration

Sidhu, A., Wersinger, C., Moussa, C., & Vernier, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.016 · Cited by 110

Modulation of α-Synuclein Aggregation by Dopamine: A Review

Leong, S. L., Cappai, R., Barnham, K. J., & Pham, C. L. L. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9986-8 · Cited by 110

Tryptophan Fluorescence Reveals Structural Features of α-Synuclein Oligomers

van Rooijen, B. D., van Leijenhorst-Groener, K. A., Claessens, M. M. A. E., & Subramaniam, V. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.021 · Cited by 110

New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy

Guerrero-Ferreira, R., Kováčik, Ľ., Ni, D., & Stahlberg, H. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.014 · Cited by 109

Structural and Functional Insights into α-Synuclein Fibril Polymorphism

Mehra, S., Gadhe, L. G., Bera, R., Sawner, A. S., & Maji, S. K. (2021) · Biomolecules · doi:10.3390/biom11101419 · Cited by 111

Cross‐linking of ubiquitin, HSP27, parkin and α‐synuclein by γ‐glutamyl‐ε‐lysine bonds in Alzheimer's neurofibrillary tangles

Nemes, Z., Devreese, B. V., Steinert, P. M., BEEUMEN, J. V., & Fésüs, L. (2004) · The FASEB Journal · doi:10.1096/fj.04-1493fje · Cited by 108

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse

Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 109

Neuronal inclusions of α‐synuclein contribute to the pathogenesis of Krabbe disease

Smith, B. R., Santos, M. B., Marshall, M. S., Cantuti‐Castelvetri, L., Lopez‐Rosas, A., Li, G., van Breemen, R. B., Claycomb, K. I., Gallea, J. I., Celej, M. S., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4328 · Cited by 107

Conversion of Wild-type α-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant

Yonetani, M., Nonaka, T., Masuda, M., Inukai, Y., Oikawa, T., Hisanaga, S., & Hasegawa, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807482200 · Cited by 109

α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons

Wu, Q., Takano, H., Riddle, D. M., Trojanowski, J. Q., Coulter, D. A., & Lee, V. M. ‐. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-19.2019 · Cited by 116

Interactions of Amyloidogenic Proteins

Giasson, B. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:49 · Cited by 106

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

Controlling the mass action of α‐synuclein in Parkinson’s disease

Kim, C., & Lee, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05612.x · Cited by 108

Amino acid determinants of α‐synuclein aggregation: putting together pieces of the puzzle

Uversky, V. N., & Fink, A. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02883-1 · Cited by 105

Neurobiology of α-Synuclein

Vekrellis, K., Rideout, H. J., & Stefanis, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:001 · Cited by 108

The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease

Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 106

Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins

Ulamec, S. M., Brockwell, D. J., & Radford, S. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.611285 · Cited by 106

Inhibiting Aggregation of α-Synuclein with Human Single Chain Antibody Fragments

Emadi, S., Liu, R., Yuan, B., Schulz, P., McAllister, C., Lyubchenko, Y. L., Messer, A. C., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi036281f · Cited by 104

The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration

Mor, D. E., Daniels, M. J., & Ischiropoulos, H. (2019) · Movement Disorders · doi:10.1002/mds.27607 · Cited by 107

Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease

Jasutkar, H. G., Oh, S. E., & Mouradian, M. M. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000133 · Cited by 104

Key genes and convergent pathogenic mechanisms in Parkinson disease

Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 116

Curvature Dynamics of α-Synuclein Familial Parkinson Disease Mutants

Perlmutter, J. D., Braun, A. R., & Sachs, J. N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808895200 · Cited by 102

Specificity and Kinetics of α-Synuclein Binding to Model Membranes Determined with Fluorescent Excited State Intramolecular Proton Transfer (ESIPT) Probe

Shvadchak, V. V., Falomir‐Lockhart, L. J., Yushchenko, D. A., & Jovin, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204776 · Cited by 102

Role of Different Regions of α-Synuclein in the Assembly of Fibrils

Qin, Z., Hu, D., Han, S., Hong, D.-P., & Fink, A. L. (2007) · Biochemistry · doi:10.1021/bi7014053 · Cited by 100

Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons

Taschenberger, G., Garrido, M., Tereshchenko, Y., Bähr, M., Zweckstetter, M., & Kügler, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0926-8 · Cited by 100

Detecting hidden sequence propensity for amyloid fibril formation

Yoon, S., & Welsh, W. J. (2004) · Protein Science · doi:10.1110/ps.04790604 · Cited by 101

Transient β -hairpin formation in α -synuclein monomer revealed by coarse-grained molecular dynamics simulation

Yu, H., Han, W., Ma, W., & Schulten, K. J. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4936910 · Cited by 99

Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization

Lurette, O., Martín-Jiménez, R., Khan, M., Sheta, R., Jean, S., Schofield, M., Teixeira, M., Rodríguez-Aller, R., Perron, I., Oueslati, A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06251-8 · Cited by 102

Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR

Madine, J., Doig, A. J., & Middleton, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja075356q · Cited by 96

Molecular Basis for Self-Assembly of a Human Host-Defense Peptide That Entraps Bacterial Pathogens

Chairatana, P., & Nolan, E. M. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5057906 · Cited by 96

Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner

Pham, C. L. L., Leong, S. L., Ali, F. E. A., Kenche, V. B., Hill, A. F., Gras, S. L., Barnham, K. J., & Cappai, R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.007 · Cited by 99

Role of Individual Methionines in the Fibrillation of Methionine-Oxidized α-Synuclein

Hokenson, M. J., Uversky, V. N., Goers, J. W. F., Yamin, G., Munishkina, L. A., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi049979h · Cited by 97

Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils

Ayers, J. I., Brooks, M., Rutherford, N. J., Howard, J. K., Sorrentino, Z. A., Riffe, C. J., & Giasson, B. I. (2016) · Journal of Virology · doi:10.1128/jvi.02095-16 · Cited by 97

Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions

Sorrentino, Z. A., Vijayaraghavan, N., Gorion, K.-M. M., Riffe, C. J., Strang, K. H., Caldwell, J. D., & Giasson, B. I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005603 · Cited by 97

α-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy

Gai, W. P., Pountney, D. L., Power, J. H. T., Li, Q. X., Culvenor, J. G., McLean, C., Jensen, P. H., & Blumbergs, P. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00004-9 · Cited by 96

Cellular Oligomerization of α-Synuclein Is Determined by the Interaction of Oxidized Catechols with a C-terminal Sequence

Mazzulli, J. R., Armakola, M., Bridi, M., Parastatidis, I., & Ischiropoulos, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704737200 · Cited by 93

Molecular determinants of the aggregation behavior of α‐ and β‐synuclein

Rivers, R. C., Kumita, J. R., Tartaglia, G. G., Dedmon, M. M., Pawar, A. P., Vendruscolo, M., Dobson, C. M., & Christodoulou, J. (2008) · Protein Science · doi:10.1110/ps.073181508 · Cited by 97

Interaction of α-synuclein with biomembranes in Parkinson's disease —role of cardiolipin

Ghio, S., Kamp, F., Cauchi, R. J., Giese, A., & Vassallo, N. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.005 · Cited by 95

Advanced glycation end products induce in vitro cross‐linking of α‐synuclein and accelerate the process of intracellular inclusion body formation

Shaikh, S. B., & Nicholson, L. F. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21644 · Cited by 92

Advanced Solid-State NMR Approaches for Structure Determination of Membrane Proteins and Amyloid Fibrils

Tang, M., Comellas, G., & Rienstra, C. M. (2013) · Accounts of Chemical Research · doi:10.1021/ar4000168 · Cited by 91

α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking

Lou, X., Kim, J., Hawk, B. J. D., & Shin, Y. (2017) · Biochemical Journal · doi:10.1042/bcj20170200 · Cited by 98

Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders

Messer, A. C., & Butler, D. C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104619 · Cited by 91

Membrane binding, internalization, and sorting of alpha-synuclein in the cell

Masaracchia, C., Hnida, M., Gerhardt, E., da Fonseca, T. L., Villar‐Piqué, A., Branco, T., Stahlberg, M. A., Dean, C., Fernández, C. O., Milošević, I., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0578-1 · Cited by 92

The Cellular Environment Affects Monomeric α-Synuclein Structure

Stephens, A. D., Zacharopoulou, M., & Schierle, G. S. K. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.005 · Cited by 91

Book Review: Iron and Parkinson’s Disease

Wolozin, B. L., & Golts, N. (2002) · The Neuroscientist · doi:10.1177/107385840200800107 · Cited by 89

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology

Longhena, F., Faustini, G., Spillantini, M. G., & Bellucci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010141 · Cited by 89

The role of water in the primary nucleation of protein amyloid aggregation

Camino, J. D., Gracia, P., & Cremades, N. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106520 · Cited by 87

Models of Parkinson's disease

Orth, M., & Tabrizi, S. J. (2003) · Movement Disorders · doi:10.1002/mds.10447 · Cited by 87

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein

Sacino, A. N., Brooks, M., McGarvey, N. H., McKinney, A. B., Thomas, M. A., Levites, Y., Ran, Y., Golde, T. E., & Giasson, B. I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-38 · Cited by 88

Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration

Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130216 · Cited by 89

An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model

Hashimoto, M., Rockenstein, E. M., Mante, M., Crews, L. A., Bar‐On, P., Gage, F. H., Marr, R. A., & Masliah, E. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302349 · Cited by 86

Combined Effects of Agitation, Macromolecular Crowding, and Interfaces on Amyloidogenesis

Lee, C. F., Bird, S. H., Shaw, M. K., Jean, L., & Vaux, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400580 · Cited by 87

α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters

Chistiakov, D. A., & Chistiakov, A. A. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0679-1 · Cited by 87

The significance of tau and α-synuclein inclusions in neurodegenerative diseases

Goedert, M. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00200-8 · Cited by 86

The Fluorescent Congo Red Derivative, (Trans, Trans)−1-Bromo-2,5-Bis-(3-Hydroxycarbonyl-4-Hydroxy)Styrylbenzene (BSB), Labels Diverse β-Pleated Sheet Structures in Postmortem Human Neurodegenerative Disease Brains

Schmidt, M. L., Schuck, T., Sheridan, S., Kung, M., Kung, H. F., Zhuang, Z., Bergeron, C., Lamarche, J. S., Skovronsky, D., Giasson, B. I., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61769-5 · Cited by 86

Characterization of α-Synuclein Interactions with Selected Aggregation-Inhibiting Small Molecules

Rao, J. N., Dua, V., & Ulmer, T. S. (2008) · Biochemistry · doi:10.1021/bi8002378 · Cited by 85

Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Russo, I., Bubacco, L., & Greggio, E. (2012) · Europe PMC (PubMed Central) · Cited by 85

Structure/function of α‐synuclein in health and disease: rational development of animal models for Parkinson's and related diseases

Kahle, P. J., Haass, C., Kretzschmar, H. A., & Neumann, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01020.x · Cited by 86

Evidence of distinct α-synuclein strains underlying disease heterogeneity

Holec, S. A. M., & Woerman, A. L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02163-5 · Cited by 91

Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease

Wu, K., Xu, Q., Liu, Y., Feng, Y., Han, S., Zhang, Y.-R., Chen, S.-D., Guo, Y. X., Wu, B., Ma, L., et al. (2025) · Science · doi:10.1126/science.adp3645 · Cited by 85

Alpha-synuclein dysfunction in Lewy body diseases

Tofaris, G. K., & Spillantini, M. G. (2005) · Movement Disorders · doi:10.1002/mds.20538 · Cited by 87

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

Sorrentino, Z. A., Goodwin, M. S., Riffe, C. J., Dhillon, J.-K. S., Xia, Y., Gorion, K.-M. M., Vijayaraghavan, N., McFarland, K. N., Golbe, L. I., Yachnis, A. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0787-2 · Cited by 86

Oxidative Modifications of α‐Synuclein

Ischiropoulos, H. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07466.x · Cited by 84

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

Altay, M. F., Liu, A. K. L., Holton, J. L., Parkkinen, L., & Lashuel, H. A. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01468-8 · Cited by 85

Amyloidogenic sequences in native protein structures

Tzotzos, S. J., & Doig, A. J. (2009) · Protein Science · doi:10.1002/pro.314 · Cited by 84

Pathogenic effects of α-synuclein aggregation

Lundvig, D. M. S., Lindersson, E., & Jensen, P. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.001 · Cited by 83

The phosphorylation of α‐synuclein: development and implication for the mechanism and therapy of the Parkinson's disease

Xu, Y., Deng, Y., & Qing, H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13234 · Cited by 87

Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity

Ysselstein, D., Joshi, M. K., Mishra, V. R., Griggs, A. M., Asiago, J. M., McCabe, G. P., Stanciu, L., Post, C. B., & Rochet, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.007 · Cited by 86

Interactions between Calcium and Alpha-Synuclein in Neurodegeneration

Rcom-H'cheo-Gauthier, A. N., Goodwin, J., & Pountney, D. L. (2014) · Biomolecules · doi:10.3390/biom4030795 · Cited by 85

A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation

Waxman, E. A., & Giasson, B. I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06592.x · Cited by 85

Dynamic structural flexibility of α-synuclein

Mor, D. E., Ugras, S. E., Daniels, M. J., & Ischiropoulos, H. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.018 · Cited by 85

Interactions of α-synuclein oligomers with lipid membranes

Musteikytė, G., Jayaram, A. K., Xu, C. K., Vendruscolo, M., Krainer, G., & Knowles, T. P. J. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183536 · Cited by 83

γ-Synuclein: Seeding of α-Synuclein Aggregation and Transmission between Cells

Surgucheva, I. G., Sharov, V. S., & Surguchov, A. P. (2012) · Biochemistry · doi:10.1021/bi300478w · Cited by 86

Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room

Killinger, B. A., Melki, R., Brundin, P., & Kordower, J. H. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0095-3 · Cited by 82

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro

Marotta, N. P., Ara, J. E., Uemura, N., Lougee, M. G., Meymand, E. S., Zhang, B., Petersson, E. J., Trojanowski, J. Q., & Lee, V. M. ‐. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01288-2 · Cited by 84

Synucleins: New Data on Misfolding, Aggregation and Role in Diseases

Surguchov, A. P., & Surguchev, A. A. (2022) · Biomedicines · doi:10.3390/biomedicines10123241 · Cited by 82

Investigating the Effects of Mutations on Protein Aggregation in the Cell

Calloni, G., Zoffoli, S., Stefani, M., Dobson, C. M., & Chiti, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412951200 · Cited by 81

Inhibition of synucleinopathic seeding by rationally designed inhibitors

Sangwan, S., Sahay, S., Murray, K. A., Morgan, S., Guenther, E. L., Jiang, L., Williams, C. K., Vinters, H. V., Goedert, M., & Eisenberg, D. S. (2020) · eLife · doi:10.7554/elife.46775 · Cited by 79

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity

Sorrentino, Z. A., Brooks, M. M. T., Hudson, V., Rutherford, N. J., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0182-z · Cited by 79

Characterization of antibodies that selectively detect α-synuclein in pathological inclusions

Waxman, E. A., Duda, J. E., & Giasson, B. I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0375-1 · Cited by 79

Intrinsically disordered proteins in synaptic vesicle trafficking and release

Snead, D., & Eliezer, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev118.006493 · Cited by 79

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro

Köppen, J., Schulze, A., Machner, L., Wermann, M., Eichentopf, R., Guthardt, M., Hähnel, A., Klehm, J., Kriegeskorte, M.-C., Hartlage‐Rübsamen, M., et al. (2020) · Molecules · doi:10.3390/molecules25030580 · Cited by 79

Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts

Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 80

Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein

Waxman, E. A., & Giasson, B. I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22537 · Cited by 78

A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain

Fujita, M., Sugama, S., Sekiyama, K., Sekigawa, A., Tsukui, T., Nakai, M., Waragai, M., Takenouchi, T., Takamatsu, Y., Wei, J., et al. (2010) · Nature Communications · doi:10.1038/ncomms1101 · Cited by 78

Mutant Protein A30P α-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics

Lemkau, L., Comellas, G., Kloepper, K. D., Woods, W. S., George, J. M., & Rienstra, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306902 · Cited by 78

Evidence of Native α-Synuclein Conformers in the Human Brain

Gould, N. S., Mor, D. E., Lightfoot, R. T., Malkus, K. A., Giasson, B. I., & Ischiropoulos, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.538249 · Cited by 80

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3